Bio Insight BioResources
AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...
October 09, 2026 | Analysis
Method in brief What counts. A CAR-T cell therapy approved on one of seven national registers: China's NMPA, Japan's PMDA and MHLW, Korea's MFDS, ...
October 08, 2026 | Analysis
Universities and public research institutes across the region are advancing research in cancer treatment, cell therapy, biologics and other emerging fields...
October 07, 2026 | Opinion | By Hajjerah TMK Hassan, Director, Discovery and Channels - ASEAN |Cytiva
So what is the real answer to the peptide vs protein question? It mostly comes down to size and shape. A peptide is a short chain of amino acids. A protein...
October 06, 2026 | News
What Is a Peptide? First, a quick look at what is being built. Amino acids are small building-block molecules, and living things use 20 standard ones to m...
October 06, 2026 | News
How this list was built Scope. Every biotech initial public offering with a first trading day between 1 January and 24 September 2026 on five venu...
September 29, 2026 | Analysis
Asia-Pacific’s New Drug Boom: 99 Approvals, 20 World Firsts Somewhere in the second week of January, a BeOne Medicines BCL2 inhibitor called sonroto...
September 23, 2026 | Analysis
A gerotherapeutic that delays five diseases by three years each would produce savings across five budget lines over thirty years, and a cost that lands in ...
September 04, 2026 | Analysis
With cooler weather, changing schedules, and renewed motivation, it's an ideal season to establish habits that can carry you through the holidays and beyon...
September 02, 2026 | News
METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a cost-of-goods figure and none is...
September 01, 2026 | News
METHOD IN BRIEF Outcome evidence in this article is taken from published trial results and approved label language only. No efficacy or outcome claim is s...
August 31, 2026 | Analysis
Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six an...
August 18, 2026 | Analysis
Private dentists in Knightsbridge serve one of London's most affluent postcodes, yet price transparency remains surprisingly poor across the area, and veri...
August 13, 2026 | News
The challenge is real: separating genuinely trained practitioners from people marketing wellness without the science to back it up is harder than it should...
August 11, 2026 | News
Most Read
Bio Jobs
News